A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines

被引:2
|
作者
Inukai, Takeshi [1 ]
Zhang, Xiuru [2 ]
Kameyama, Takeshi [2 ]
Suzuki, Yukiko [2 ]
Yoshikawa, Kazuhito [2 ]
Kuroda, Itaru [1 ]
Nemoto, Atsushi [1 ]
Akahane, Koshi [1 ]
Sato, Hiroki [1 ]
Goi, Kumiko [1 ]
Nakamoto, Kazunori [3 ]
Hamada, Jun-ichi [2 ]
Tada, Mitsuhiro [2 ]
Moriuchi, Tetsuya [2 ]
Sugita, Kanji [1 ]
机构
[1] Univ Yamanashi, Sch Med, Dept Pediat, Yamanashi 4093898, Japan
[2] Hokkaido Univ, Inst Med Genet, Div Canc Related Genes, Sapporo, Hokkaido, Japan
[3] Univ Yamanashi, Ctr Life Sci Res, Bioinformat Support Sect, Yamanashi 4093898, Japan
关键词
APOPTOSIS-INDUCING LIGAND; P53; MUTATIONS; GENE; E2A-HLF; EXPRESSION; RESISTANCE; MECHANISM;
D O I
10.1002/ajh.21738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chromosomal translocation plays an essential role in leukemogenesis of childhood B-precursor acute lymphoblastic leukemia (ALL) in combination with specific gene mutations. Although several reports suggest correlation of TP53 mutation with the type of chromosomal translocation in childhood B-precursor ALL, it has not been directly confirmed in a single cohort study due to the limited incidence of TP53 mutation in primary samples at diagnosis. Leukemia cell lines generally show higher incidence of gene mutations compared with primary samples. Thus, to clarify possible differences in cooperation of the p53 pathway for leukemogenesis with the type of chromosomal translocation, TP53 gene mutation was analyzed in 32 B-precursor ALL cell lines. TP53 mutation was observed in 40.6% (13 cell lines), and missense mutation of R248Q was the most commonly observed (5 cell lines). Of note, TP53 mutation was frequently observed among MLL-rearranged and t(1;19)-positive ALL cell lines, but was very rare among Philadelphia chromosome-positive and t(17;19)-positive ALL cell lines. Although the number of samples analyzed is limited, this is the first direct observation of the correlation between the incidence of TP53 mutation and types of translocation in B-precursor ALLs, suggesting a functionally different fusion gene product in the p53 pathway for leukemogenesis.
引用
收藏
页码:535 / 537
页数:3
相关论文
共 50 条
  • [1] TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia
    Comeaux, Evan Q.
    Mullighan, Charles G.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (03):
  • [2] Characteristics of TP53 mutation in adult precursor B-cell acute lymphoblastic leukemia
    Samy, Heba
    Fouad, Dina A.
    Ali, Basma S. M.
    Attia, Hend
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (01): : 13 - 18
  • [3] Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
    Chitadze, Guranda
    Stengel, Anna
    John-Klaua, Cathrin
    Bruckmueller, Julien
    Trautmann, Heiko
    Kotrova, Michaela
    Darzentas, Franziska
    Kelm, Miriam
    Pal, Karol
    Darzentas, Nikos
    Bastian, Lorenz
    Kehden, Britta
    Wessels, Wiebke
    Stroeh, Aeint-Steffen
    Oberg, Hans -Heinrich
    Altrock, Philipp M.
    Baer, Constance
    Meggendorfer, Manja
    Goekbuget, Nicola
    Baldus, Claudia D.
    Haferlach, Claudia
    Brueggemann, Monika
    BLOOD, 2023, 141 (13) : 1640 - 1644
  • [4] Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia
    Gump, J
    McGavran, L
    Wei, Q
    Hunger, SP
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (07) : 416 - 419
  • [5] GERMLINE TP53 MUTATIONS IN A COHORT OF PAEDIATRIC HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA
    Bettini, L. R.
    Saitta, C.
    Buldini, B.
    Grioni, A.
    Rebellato, S.
    Silvestri, D.
    Biondi, A.
    Fazio, G.
    Cazzaniga, G.
    HAEMATOLOGICA, 2020, 105 : S89 - S89
  • [6] Focal Chromosomal Loss in B-Cell Precursor Acute Lymphoblastic Leukemia Cell Lines
    Kizuki, Toshihiko
    Watanabe, Atsushi
    Harama, Daisuke
    Murakami, Yasushi
    Akahane, Koshi
    Goi, Kumiko
    Kagami, Keiko
    Abe, Masako
    Urayama, Kevin
    Inukai, Takeshi
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S35 - S35
  • [7] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
    Forero-Castro, Maribel
    Robledo, Cristina
    Benito, Rocio
    Bodega-Mayor, Irene
    Rapado, Inmaculada
    Hernandez-Sanchez, Maria
    Abaigar, Maria
    Maria Hernandez-Sanchez, Jesus
    Quijada-Alamo, Miguel
    Maria Sanchez-Pina, Jose
    Sala-Valdes, Monica
    Araujo-Silva, Fernanda
    Kohlmann, Alexander
    Luis Fuster, Jose
    Arefi, Maryam
    de las Heras, Natalia
    Riesco, Susana
    Rodriguez, Juan N.
    Hermosin, Lourdes
    Ribera, Jordi
    Camos Guijosa, Mireia
    Ramirez, Manuel
    de Heredia Rubio, Cristina Diaz
    Barragan, Eva
    Martinez, Joaquin
    Ribera, Jose M.
    Fernandez-Ruiz, Elena
    Hernandez-Rivas, Jesus-Maria
    BRITISH JOURNAL OF CANCER, 2017, 117 (02) : 256 - 265
  • [8] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
    Maribel Forero-Castro
    Cristina Robledo
    Rocío Benito
    Irene Bodega-Mayor
    Inmaculada Rapado
    María Hernández-Sánchez
    María Abáigar
    Jesús Maria Hernández-Sánchez
    Miguel Quijada-Álamo
    José María Sánchez-Pina
    Mónica Sala-Valdés
    Fernanda Araujo-Silva
    Alexander Kohlmann
    José Luis Fuster
    Maryam Arefi
    Natalia de las Heras
    Susana Riesco
    Juan N Rodríguez
    Lourdes Hermosín
    Jordi Ribera
    Mireia Camos Guijosa
    Manuel Ramírez
    Cristina Díaz de Heredia Rubio
    Eva Barragán
    Joaquín Martínez
    José M Ribera
    Elena Fernández-Ruiz
    Jesús-María Hernández-Rivas
    British Journal of Cancer, 2017, 117 : 256 - 265
  • [9] B-Cell Acute Lymphoblastic Leukemia Arising in Patients with a Preexisting Diagnosis of Multiple Myeloma Is a Novel Cancer with High Incidence of TP53 Mutations
    Chavez, Monique
    Barnell, Erica
    Griffith, Malachi
    Skidmore, Zachary
    Griffith, Obi
    Tian, Ling
    Wartman, Lukas D.
    BLOOD, 2020, 136
  • [10] LNK (SH2B3) Synergizes with TP53 in Suppressing B-Precursor Acute Lymphoblastic Leukemia through IL-7 Receptor Signaling
    Cheng, Ying
    Chikwava, Kudakwashe
    Wu, Chao
    Bhagat, Anchit
    Choi, John K.
    Tong, Wei
    BLOOD, 2014, 124 (21)